Feride KARACAER

Diabetik Kardiyovasküler Otonomik Nöropatide Anestezi Yönetimi

Kardiyovasküler otonomik nöropati, diabetes mellitusu olan hastalarda sıklıkla gözlenmekte ve otonomik sinir liflerinin hasarlanmasıyla kalp hızı kontrolü ve vasküler dinamiklerde anormalliklere neden olmaktadır. Bu hastalarda mortalite ve morbidite artışı bulunmaktadır. Kardiyak otonomik nöropati tanısında Ewing testleri olarak bilinen bir dizi kardiyovasküler refleks testi kullanılmakta ve hastaların klinik değerlendirilmesinde değerli bilgiler sağlamaktadır. Anestezi perioperatif otonomik fonksiyon üzerinde belirgin etkiye sahip olduğu için kardiyovasküler otonomik nöropati ve anestezi arasındaki ilişki cerrahi sırasında ve postoperatif derlenme döneminde beklenmeyen hemodinamik instabilite i|e sonuçlanabilir. Başarılı bir anestezi yönetimi için kapsamlı preoperatif değerlendirme ve dikkatli monitorizasyon gerekmektedir.

Anesthesia Management in Diabetic Cardiovascular Autonomic Neuropathy

Cardiovascular autonomic neuropathy is frequently observed in patients with diabetes mellitus and encompasses damage to the autonomic nerve fibers, resulting in abnormalities in heart rate control and vascular dynamics. There is an increased mortality and morbidity rate among these patients. series of cardiovascular reflex tests known as Ewing’s battery tests are used for diagnosis cardiac autonomic neuropathy and provide valuable information to the clinical assessment of these patients. As anesthesia has major influence on perioperative autonomic function, the interplay between cardiovascular autonomic neuropathy and anesthesia may result in unexpected haemodynamic instability during surgery and postoperative recovery. comprehensive preoperative assessment and perioperative cautious monitoring are necessary for successful anesthesia management.

PDF

___

1. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:155379.
2. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a metaanalysis. Diabetes Care. 2003;6:1895–1901.
3. Maser R, Lenhard M, DeCherney G. Cardiovascular autonomic neuropathy: the clinical significance of its determination. Endocrinologist. 2000;10:27–33.
4. Jermendy G. Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients. Acta Diabetol. 2003; 40:3704.
5. Neukirchen M, Kienbaum P. Sympathetic nervous system: evaluation and importance for clinical general anesthesia. Anesthesiology. 2008; 109:111331.
6. Ziegler D, Zentai C, Perz S, Rathmann W, Haastert B, Meisinger C, Lowel H. Diminished heart rate variability (HRV) and prolonged QTc interval, but not increased QT dispersion (QTD) are predicators of mortality in the diabetic population. Diabetes. 2004;53:A57.
7. Burgos LG, Ebert TJ, Asiddao C, Turner LA, Pattison CZ, WangCheng R et al. Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology. 1989;70:591–7.
8. Knüttgen D, ButtnerBelz U, Gernot A, Doehn M. Unstable blood pressure during anesthesia in diabetic patients with autonomic neuropathy. Anasthesie, Intensivtherapie, Notfallmedizin. 1990;25: 256–62.
9. Knüttgen D, Weidemann D, Doehn M. Diabetic autonomic neuropathy: abnormal cardiovascular reactions under general anesthesia. Klinische Wochenschrift.1990;68:1168–72.
10. Linstedt U, Jaeger H, Petry A. The neuropathy of the autonomic nervous system. An additional anesthetic risk in diabetes mellitus. Anaesthesist.1993;42:521–7.
11. Kadoi Y. Perioperative considerations in diabetic patients. Curr Diabetes Rev.2010;6:236–46.
12. Kadoi Y. Anaesthetic considerations in diabetic patients. Part II: intraoperative and postoperative management of patients with diabetes mellitus. J Anesth. 2010;24:748–56.
13. Weston PJ, Gill GV. Is undetected autonomic dysfunction responsible for sudden death in type 1 diabetes mellitus? the “dead in bed” syndrome revisited. Diabet Med. 1999;16:626–31.
14. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:38797.
15. Maser RE, Lenhard MJ. Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab. 2005;90:5896903.
16. Oakley I, Emond L. Diabetic cardiac autonomic neuropathy and anesthetic management: review of the literature. AANA J. 2011;79:4739.
17. Amour J, Kersten JR. Diabetic cardiomyopathy and anesthesia: bench to bedside. Anesthesiology. 2008;108:52430.
18. Temamoğulları AV, Sucu MM, Temam Y, Batıraliyev T. İskemik olmayan diyabetik otonomik nöropatili hastalarda tredmil egzersiz testi parametreleri ile kalp hızı değikenlerinin değerlendirilmesi. Türk Kardiyol Dern Ar. 2006;34:3527.
19. Airaksinen KEJ. Silent coronary artery disease in diabetes a feature of autonomic neuropathy or accelerated atherosclerosis? Diabetologia 2001;44:259–66.
20. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:95662.
21. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27:1954–61.
22. Vinik A, Erbas T. Neuropathy. In Handbook of Exercise in Diabetes. 2nd edition (Eds N Ruderman, JT Devlin, SH Schneider, A Kriska):46396. Alexandria, Va, American Diabetes Association; 2001.
23. Giunti S, Bruno G, Lillaz E, Gruden G, Lolli V, Chaturvedi N et al; EURODIAB IDDM Complications Study Group. Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care. 2007;30:205763.
24. Kahn JK, Sisson JC, Vinik AI. QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. J Clin Endocrinol Metab. 1987;64:7514.
25. Metin M, Uluçam M, Aksoy A, Çakır N, Çengel A, Dörtlemez Ö et al. Diyabetik kardiyak otonom nöropatide QT uzaması. Turkiye Klinikleri J Cardiol.1991;4:24650.
26. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med. 1980;49:95108.
27. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985;8:4918.
28. Keet SW, Bulte CS, Sivanathan S, Verhees L, Allaart CP, Boer C et al. Cardiovascular autonomic function testing under nonstandardised conditions in cardiovascular patients with type2 diabetes mellitus. Anaesthesia.2014;69:476–83.
29. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J. 1982;285:9168.
30. Keet SW, Bulte CS, Garnier RP, Boer C, Bouwman RA. Shortterm heart rate variability in healthy subjects. Anaesthesia.2013;68:775–7.
31. Khandoker AH, Jelinek HF, Palaniswami M. Identifying diabetic patients with cardiac autonomic neuropathy by heart rate complexity analysis. Biomed Eng Online. 2009;8:3.
32. Gulli G, Fattor B, Marchesi M. Crossspectral analysis of cardiovascular variables in supine diabetic patients. Clin Auton Res. 2005;15:928.
33. Keet SW, Bulte CS, Sivanathan S, Verhees L, Allaart CP, Boer C et al. Cardiovascular autonomic function testing under nonstandardised conditions in cardiovascular patients with type2 diabetes mellitus. Anaesthesia.2014;69:476–83.
34. Keet SW, Bulte CS, Garnier RP, Boer C, Bouwman RA. Shortterm heart rate variability in healthy subjects. Anaesthesia.2013;68:775–7.
35. Bulte CS, Keet SW, Boer C, Bouwman RA. Level of agreement between heart rate variability and pulse rate variability in healthy individuals. Eur J Anaesthesiol. 2011;28:34–8.
36. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation.1996;93:1043–65.
37. Pappachan JM, Sebastian J, Bino BC, Jayaprakash K, Vijayakumar K, Sujathan P et al. Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis. Postgrad Med J. 2008;84:20510.
38. Eagle KA, Froehlich JB. Reducing cardiovascular risk in patients undergoing noncardiac surgery. N Engl J Med. 1996;335:1761–3.
39. Robertshaw HJ, Hall GM. Diabetes mellitus: anaesthetic management. Anaesthesia. 2006;61:118790.
40. Knüttgen D, Trojan S, Weber M, Wolf M, Wappler F. Preoperative measurement of heart rate variability in diabetics: a method to estimate blood pressure stability during anaesthesia induction. Anaesthesist.2005;54: 442–9.
41. Keyl C, Lemberger P, Palitzsch KD, Hochmuth K, Liebold A, Hobbhahn J. Cardiovascular autonomic dysfunction and hemodynamic response to anesthetic induction in patients with coronary artery disease and diabetes mellitus. Anesth Analg. 1999;88:98591.
42. Lankhorst S, Keet SWM, Bulte CSE, Boer C. The impact of autonomic dysfunction on perioperative cardiovascular complications. Anaesthesia. 2015;70:33643.